GLP-1 Agonist Updates

Danny discusses the FDA approval of GLP-1 agonist drugs for weight loss in non-diabetic obese individuals, highlighting the complexities of BMI in assessing muscular individuals like bodybuilders. He explains the differences between semaglutide injections for type 2 diabetes and weight loss, shedding light on the evolving criteria for prescribing these medications.

In this clip
From this podcast
Dynamic Dialogue with Danny Matranga
369: Podcast Episode Notes: The Truth About Ozempic, Exercise and Skin Aging, Training Around Injury + More
Related Questions
- How effective are GLP-1 agonists like Ozempic for weight loss as discussed in the episode 636. Ozempic, Protein, Weight Loss + Why Muscle is Essential for Health and the clip Medication Insights?
- How effective are GLP-1 agonists like Ozempic for weight loss based on the episode 636. Ozempic, Protein, Weight Loss + Why Muscle is Essential for Health and the clip Medication Insights?